Table 1.

The expression levels of RPL23AP53 depending on clinicopathological parameters in The Cancer Genome Atlas (TCGA) melanoma patients; p < 0.05 considered as significant

Parameter	Group	Cases	RPL23AP53
			Mean ± SEM	p-value
Gender	Male	290	0.3804 ± 0.05149	0.2386
	Female	178	0.3172 ± 0.06585
Age	≤ 58	236	0.344 ± 0.05770	0.6921
	> 58	227	0.3663 ± 0.05737
Ulceration	Yes	167	0.3449 ± 0.07375	0.3751
	No	147	0.3088 ± 0.06253
Clark level	I	6	−0.8354 ± 0.8310	0.2577
	II	18	0.4998 ± 0.1706
	III	78	0.4666 ± 0.06916
	IV	167	0.3722 ± 0.06869
	V	53	0.2564 ± 0.1158
Breslow depth	< 1.0	51	0.3575 ± 0.08995	0.8240
	1.0–2.0	88	0.406 ± 0.08832
	2.1–4.0	78	0.4712 ± 0.07299
	> 4.0	143	0.3458 ± 0.08105
Mitotic rate	<1	3	0.44 ± 0.6814	0.8363
	1–4	65	0.369 ± 0.08878
	> 4	88	0.3793 ± 0.09413
M Stage	M0	418	0.3572 ± 0.04292	0.8753
	M1	24	0.3756 ± 0.1354
T Stage	T0	23	0.3326 ± 0.1736	0.5480
	T1–T2	121	0.3088 ± 0.07192
	T3–T4	244	0.383 ± 0.05653
Cancer Type	Cutaneous melanoma	69	0.3008 ± 0.1088	0.3570
	Desmoplastic melanoma	3	0.826 ± 0.3703
	Melanoma	28	0.1691 ± 0.1249
	Acral melanoma	2	0.627 ± 0.4657
	Lentigo maligna melanoma	1	1.186 ± 0.0
Neoplasm disease stage	0	6	−0.8765 ± 0.8283	0.1866
	I–II	218	0.3859 ± 0.05387
	III–IV	194	0.3584 ± 0.06433

SEM — standard error of the mean